On April 7, 2022, Viz.ai, a leading AI-powered disease detection and care coordination platform, announced it has raised a $100 million funding round at a $1.2 billion valuation. The Series D round was led by Tiger Global and Insight Partners. Early backers, including Scale Ventures, Kleiner Perkins, Threshold, GV (formerly Google Ventures), Sozo Ventures, CRV, and Suza also participated in the round. The new funds will be used to support Viz.ai's growth, expand the "Viz Platform" to detect and triage additional diseases, and grow its customer base globally.

Wilson Sonsini Goodrich & Rosati represented Viz.ai in the transaction. The team advising Viz.ai was led by Rezwan Pavri, Lang Liu, Lester Ang, Alex Youssef, and Olivia Cusimano.

For more information, please see Viz.ai’s press release.